MicroRNA Biomarkers for Coronary Artery Disease?
MicroRNA (miRNA, miR) measurements in patients with coronary heart disease are hampered by the confounding effects of medication commonly used in cardiovascular patients such as statins, antiplatelet drugs, and heparin administration. Statins reduce the circulating levels of liver-derived miR-122. A...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Springer US
2015
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613887/ |